nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
April 25, 2024 09:29 ET | Mainz BioMed NV
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Full Year 2023 Financial Results
April 09, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Reports Full Year 2023 Financial Results
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
March 19, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
nasdaq-mynz-mainzbiomed.png
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
March 18, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
March 12, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
March 05, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
February 27, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
February 22, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
February 21, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
February 06, 2024 08:01 ET | Mainz BioMed NV
MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY